Zhou Y, Yang X, Hong C, Guan T, Xiao P, Yang Y
Biology (Basel). 2025; 14(2).
PMID: 40001962
PMC: 11851986.
DOI: 10.3390/biology14020193.
Umumararungu T, Gahamanyi N, Mukiza J, Habarurema G, Katandula J, Rugamba A
Amino Acids. 2024; 56(1):50.
PMID: 39182198
PMC: 11345334.
DOI: 10.1007/s00726-024-03410-9.
Zhang H, Wen W, Wang Y, Lu Z, Liu J, Wu Z
Chem Sci. 2024; 15(32):12983-12988.
PMID: 39148795
PMC: 11322975.
DOI: 10.1039/d4sc03398a.
Fontana A, Poli A, Gour J, Srikanth Y, Anastasi N, Ashok D
J Med Chem. 2024; 67(8):6119-6143.
PMID: 38626917
PMC: 11056993.
DOI: 10.1021/acs.jmedchem.3c01909.
Silva-Reis S, Sampaio-Dias I, Costa V, Correia X, Costa-Almeida H, Garcia-Mera X
ACS Chem Neurosci. 2023; 14(4):554-572.
PMID: 36735764
PMC: 9936549.
DOI: 10.1021/acschemneuro.2c00675.
A stereochemical journey around spirocyclic glutamic acid analogs.
Chernykh A, Chernykh A, Radchenko D, Chheda P, Rusanov E, Grygorenko O
Org Biomol Chem. 2022; 20(15):3183-3200.
PMID: 35348173
PMC: 10170626.
DOI: 10.1039/d2ob00146b.
Structure, Function, and Pharmacology of Glutamate Receptor Ion Channels.
Hansen K, Wollmuth L, Bowie D, Furukawa H, Menniti F, Sobolevsky A
Pharmacol Rev. 2021; 73(4):298-487.
PMID: 34753794
PMC: 8626789.
DOI: 10.1124/pharmrev.120.000131.
A step-economic and one-pot access to chiral C-tetrasubstituted α-amino acid derivatives a bicyclic imidazole-catalyzed direct enantioselective -acylation.
Wang M, Zhou M, Zhang L, Zhang Z, Zhang W
Chem Sci. 2021; 11(18):4801-4807.
PMID: 34122937
PMC: 8159231.
DOI: 10.1039/d0sc00808g.
Use of the 4-Hydroxytriazole Moiety as a Bioisosteric Tool in the Development of Ionotropic Glutamate Receptor Ligands.
Sainas S, Temperini P, Farnsworth J, Yi F, Mollerud S, Jensen A
J Med Chem. 2019; 62(9):4467-4482.
PMID: 30943028
PMC: 6508984.
DOI: 10.1021/acs.jmedchem.8b01986.
Neuroprotective Activity of Sitagliptin via Reduction of Neuroinflammation beyond the Incretin Effect: Focus on Alzheimer's Disease.
Wicinski M, Wodkiewicz E, Slupski M, Walczak M, Socha M, Malinowski B
Biomed Res Int. 2018; 2018:6091014.
PMID: 30186862
PMC: 6116461.
DOI: 10.1155/2018/6091014.
Do GluN2B subunit containing NMDA receptors tolerate a fluorine atom in the phenylalkyl side chain?.
Shuto Y, Thum S, Temme L, Schepmann D, Kitamura M, Wunsch B
Medchemcomm. 2018; 8(5):975-981.
PMID: 30108812
PMC: 6072303.
DOI: 10.1039/c6md00621c.
Synthesis, Immunosuppressive Properties, and Mechanism of Action of a New Isoxazole Derivative.
Maczynski M, Borska S, Mieszala K, Kocieba M, Zaczynska E, Kochanowska I
Molecules. 2018; 23(7).
PMID: 29949951
PMC: 6099534.
DOI: 10.3390/molecules23071545.
In Silico Analysis of the Association Relationship between Neuroprotection and Flavors of Traditional Chinese Medicine Based on the mGluRs.
Zhang X, Qiao L, Chen Y, Zhao B, Gu Y, Huo X
Int J Mol Sci. 2018; 19(1).
PMID: 29320397
PMC: 5796112.
DOI: 10.3390/ijms19010163.
Interactions between the Kynurenine and the Endocannabinoid System with Special Emphasis on Migraine.
Nagy-Grocz G, Zador F, Dvoracsko S, Bohar Z, Benyhe S, Tomboly C
Int J Mol Sci. 2017; 18(8).
PMID: 28758944
PMC: 5578009.
DOI: 10.3390/ijms18081617.
Subtype-Specific Agonists for NMDA Receptor Glycine Binding Sites.
Maolanon A, Risgaard R, Wang S, Snoep Y, Papangelis A, Yi F
ACS Chem Neurosci. 2017; 8(8):1681-1687.
PMID: 28514141
PMC: 5559341.
DOI: 10.1021/acschemneuro.7b00117.
A parallel panning scheme used for selection of a GluA4-specific Fab targeting the ligand-binding domain.
Clausen R, Mohr A, Riise E, Jensen A, Gill A, Madden D
Int J Biol Macromol. 2016; 92:779-787.
PMID: 27402461
PMC: 5145273.
DOI: 10.1016/j.ijbiomac.2016.07.026.
Novel GluN2B selective NMDA receptor antagonists: relative configuration of 7-meth-oxy-2-methyl-2,3,4,5-tetra-hydro-1H-3-benzazepin-1-ols.
Tewes B, Frehland B, Frohlich R, Wunsch B
Acta Crystallogr E Crystallogr Commun. 2016; 72(Pt 5):687-91.
PMID: 27308019
PMC: 4908524.
DOI: 10.1107/S2056989016005843.
Crystal structure of (1S*,2R*)-7-benz-yloxy-2-methyl-3-tosyl-2,3,4,5-tetra-hydro-1H-3-benz-azepin-1-ol: elucidation of the relative configuration of potent allosteric GluN2B selective NMDA receptor antagonists.
Tewes B, Frehland B, Frohlich R, Wunsch B
Acta Crystallogr E Crystallogr Commun. 2016; 72(Pt 5):683-6.
PMID: 27308018
PMC: 4908544.
DOI: 10.1107/S2056989016005855.
Analogues of 3-hydroxyisoxazole-containing glutamate receptor ligands based on the 3-hydroxypyrazole-moiety: design, synthesis and pharmacological characterization.
Jorgensen L, Nielsen B, Pickering D, Kristensen A, Frydenvang K, Madsen U
Neurochem Res. 2014; 39(10):1895-905.
PMID: 24848194
DOI: 10.1007/s11064-014-1332-0.
The role of metabotropic glutamate receptor 5 on the stromal cell-derived factor-1/CXCR4 system in oral cancer.
Kuribayashi N, Uchida D, Kinouchi M, Takamaru N, Tamatani T, Nagai H
PLoS One. 2013; 8(11):e80773.
PMID: 24236200
PMC: 3827474.
DOI: 10.1371/journal.pone.0080773.
